Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Dose Corticosteroids for Immune Reconstitution Inflammatory Syndrome in Patients Who Develop Progressive Multifocal Leukoencephalopathy on Natalizumab

NCT01211665 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01211665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01211665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Dose Corticosteroids for Immune Reconstitution Inflammatory Syndrome in Patients Who Develop Progressive Multifocal Leukoencephalopathy on Natalizumab
Lead sponsor
Biogen
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2010
Completion date
February 29, 2012
Enrollment
3 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

immune reconstitution inflammatory syndrome, leukoencephalopathy, progressive multifocal